1.04
-0.01 (-0.95%)
| Penutupan Terdahulu | 1.05 |
| Buka | 1.06 |
| Jumlah Dagangan | 80,000 |
| Purata Dagangan (3B) | 429,809 |
| Modal Pasaran | 2,108,837,632 |
| Harga / Pendapatan (P/E TTM) | 104.00 |
| Harga / Jualan (P/S) | 1.06 |
| Harga / Buku (P/B) | 0.790 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 26 Aug 2025 - 1 Sep 2025 |
| Margin Keuntungan | 0.31% |
| Margin Operasi (TTM) | 4.11% |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -3.90% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -85.40% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 46.18% |
| Nisbah Semasa (MRQ) | 1.24 |
| Aliran Tunai Operasi (OCF TTM) | 40.64 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -10.16 M |
| Pulangan Atas Aset (ROA TTM) | 0.88% |
| Pulangan Atas Ekuiti (ROE TTM) | 0.18% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (HK) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | FRONTAGE | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 3.5 |
| Osilator Teknikal | -0.5 |
| Purata | 0.88 |
Saham Serupa
| Stok | Modal Pasaran | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| FRONTAGE | 2 B | - | 104.00 | 0.790 |
| ALPHAMAB-B | 10 B | - | 41.23 | 5.23 |
| LEPU BIO-B | 10 B | - | - | 12.92 |
| ABBISKO-B | 9 B | - | 57.20 | 3.83 |
| CSTONE PHARMA-B | 9 B | - | - | 23.87 |
| GENOR-B | 2 B | - | 54.43 | 1.47 |
|
Frontage Holdings Corp is a contract research organization providing integrated, scientifically driven research, analytical, and development services. Geographically the group operates in both PRC and North America. The services provided in the North American segment, include drug discovery, drug development, pharmaceutical product development, and laboratory testing in the USA and Canada; and the PRC segment includes the same services provided in the People's Republic of China. The company generates a majority of its revenue from USA followed by the PRC and the rest of the world. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 73.38% |
| % Dimiliki oleh Institusi | 0.39% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |